Biovian Revenue and Competitors
Estimated Revenue & Valuation
- Biovian's estimated annual revenue is currently $34.6M per year.
- Biovian's estimated revenue per employee is $201,000
Employee Data
- Biovian has 172 Employees.
- Biovian grew their employee count by 38% last year.
Biovian's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO | Reveal Email/Phone |
2 | CFO and Debuty CEO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Head Business Development | Reveal Email/Phone |
5 | Director, Manufacturing and development | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | Director, HR | Reveal Email/Phone |
8 | Director, Project Management | Reveal Email/Phone |
9 | Director, Gene Therapy Production | Reveal Email/Phone |
10 | Production Manager | Reveal Email/Phone |
Biovian Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Biovian?
Biovian is a One-Stop-Shop GMP CDMO in biopharmaceuticals, covering services from early development to finished vial. Biovian's 4000 m2 facilities are EMA certified and FDA inspected for GMP production of investigational and commercial products. Biovian GMP services: -Virus production for gene therapy and vaccines -Microbial production of recombinant proteins and plasmid DNA -Process development -Formulation -Fill & Finish -Analytical quality control -Cell and virus bank preparation
keywords:N/A
N/A
Total Funding
172
Number of Employees
$34.6M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biovian News
Finnish company, Biovian Oy, has been engaged by a South Korea biotechnology company to carry out process development and manufacturing of...
CDMO Biovian Oy says it has the capacity to support viral vector needs through trials and beyond for ANLBIO from its Turku,...
... FinVector, MolMed, MassBiologics, FUJIFILM Diosynth Biotechnologies, Lonza, Cell and Gene Therapy Catapult, Biovian, Brammer Bio.
Viral Vectors And Plasmid Dna Manufacturing Market 2019 Trending Technology And Forecast To 2026| Oxford BioMedica , MolMed , Biovian , ...
... Global Viral Vectors and Plasmid DNA Manufacturing Market: Aldevron, Eurogentec, Richter-Helm, BioReliance, Biovian, Brammer Bio, Cell ...
Other Companies in Turku
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 174 | -1% | N/A |
#2 | $67.8M | 258 | 8% | N/A |
#3 | $3.5M | 477 | 12% | N/A |
#4 | N/A | 561 | 8% | N/A |
#5 | N/A | 996 | 298% | N/A |